These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16164152)

  • 21. Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel.
    Cook-Bolden FE
    J Drugs Dermatol; 2012 Apr; 11(4):455-9. PubMed ID: 22453581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
    Eichenfield LF; Alió Sáenz AB
    J Drugs Dermatol; 2011 Dec; 10(12):1382-96. PubMed ID: 22134562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical efficacy of Velac, a new tretinoin and clindamycin phosphate gel in acne vulgaris.
    Cambazard F
    J Eur Acad Dermatol Venereol; 1998 Sep; 11 Suppl 1():S20-7; discussion S28-9. PubMed ID: 9891905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tretinoin gel microsphere pump 0.04% plus 5% benzoyl peroxide wash for treatment of acne vulgaris: morning/morning regimen is as effective and safe as morning/evening regimen.
    Pariser D; Bucko A; Fried R; Jarratt MT; Kempers S; Kircik L; Lucky AW; Rafal E; Rendon M; Weiss J; Wilson DC; Rossi AB; Ramaswamy R; Nighland M
    J Drugs Dermatol; 2010 Jul; 9(7):805-13. PubMed ID: 20677537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The stability of tretinoin in tretinoin gel microsphere 0.1%.
    Nyirady J; Lucas C; Yusuf M; Mignone P; Wisniewski S
    Cutis; 2002 Nov; 70(5):295-8. PubMed ID: 12469785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tretinoin microsphere gel 0.04% pump for treating acne vulgaris in preadolescents: a randomized, controlled study.
    Eichenfield LF; Hebert AA; Schachner L; Paller AS; Rossi AB; Lucky AW
    Pediatr Dermatol; 2012; 29(5):598-604. PubMed ID: 22712470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination topical therapy in the treatment of acne.
    Del Rosso JQ
    Cutis; 2006 Aug; 78(2 Suppl 1):5-12. PubMed ID: 17966494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical therapy for acne vulgaris. How do you choose the best drug for each patient?
    Johnson BA; Nunley JR
    Postgrad Med; 2000 Mar; 107(3):69-70, 73-6, 79-80. PubMed ID: 10728136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A combined analysis of 2 randomized clinical studies of tretinoin gel 0.05% for the treatment of acne.
    Webster G; Cargill DI; Quiring J; Vogelson CT; Slade HB
    Cutis; 2009 Mar; 83(3):146-54. PubMed ID: 19363908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of a ceramide containing moisturizer followed by fixed-dose clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel in the morning in combination with a ceramide containing moisturizer followed by tretinoin 0.05% gel in the evening for the treatment of facial acne vulgaris.
    Zeichner JA; Patel RV; Haddican M; Wong V
    J Drugs Dermatol; 2012 Jun; 11(6):748-52. PubMed ID: 22648223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of simulated solar UV irradiation on tretinoin in tretinoin gel microsphere 0.1% and tretinoin gel 0.025%.
    Nighland M; Yusuf M; Wisniewski S; Huddleston K; Nyirady J
    Cutis; 2006 May; 77(5):313-6. PubMed ID: 16776288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative trial of two retinoids commonly used in the treatment of acne vulgaris.
    Nyirady J; Grossman RM; Nighland M; Berger RS; Jorizzo JL; Kim YH; Martin AG; Pandya AG; Schulz KK; Strauss JS
    J Dermatolog Treat; 2001 Sep; 12(3):149-57. PubMed ID: 12243706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative efficacy and safety results of two topical combination acne regimens.
    Kircik LH
    J Drugs Dermatol; 2009 Jul; 8(7):624-30. PubMed ID: 19588638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic options.
    Bikowski J; Callender VD; Del Rosso JQ; Draelos ZD; Tanghetti E
    Cutis; 2006 Aug; 78(2 Suppl 1):13-20. PubMed ID: 17966495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tretinoin microsphere gel in facial acne vulgaris: a meta-analysis.
    Nighland M; Grossman R
    J Drugs Dermatol; 2008 Aug; 7(8 Suppl):s2-8. PubMed ID: 18724648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simplifying regimens promotes greater adherence and outcomes with topical acne medications: a randomized controlled trial.
    Yentzer BA; Ade RA; Fountain JM; Clark AR; Taylor SL; Fleischer AB; Feldman SR
    Cutis; 2010 Aug; 86(2):103-8. PubMed ID: 20919606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two randomized, double-blind, controlled trials of 2219 subjects to compare the combination clindamycin/tretinoin hydrogel with each agent alone and vehicle for the treatment of acne vulgaris.
    Leyden JJ; Krochmal L; Yaroshinsky A
    J Am Acad Dermatol; 2006 Jan; 54(1):73-81. PubMed ID: 16384759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved efficacy and tolerability of retinoic acid in acne vulgaris: a new topical formulation with cyclodextrin complex psi.
    Anadolu RY; Sen T; Tarimci N; Birol A; Erdem C
    J Eur Acad Dermatol Venereol; 2004 Jul; 18(4):416-21. PubMed ID: 15196153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of micronized tretinoin gel 0.05% and tretinoin gel microsphere 0.1% in young adolescents with acne: a post hoc analysis of efficacy and tolerability data.
    Lucky AW; Sugarman J
    Cutis; 2011 Jun; 87(6):305-10. PubMed ID: 21838089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerability of clindamycin/tretinoin gel vs. tretinoin microsphere gel and adapalene gel.
    Leyden J; Wortzman M; Baldwin EK
    J Drugs Dermatol; 2009 Apr; 8(4):383-8. PubMed ID: 19363857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.